Effects of yerba maté, a plant extract formulation ("YGD") and resveratrol in 3T3-L1 adipogenesis. (Q42703810)

5 November 2017

Effects of yerba maté, a plant extract formulation ("YGD") and resveratrol in 3T3-L1 adipogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271528&resulttype=core&format=json

13 May 2020

1 reference

1 reference

Juliana Carvalho Santos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271528&resulttype=core&format=json

13 May 2020

Marcelo Lima Ribeiro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271528&resulttype=core&format=json

13 May 2020

author name string

Erica M F Gotardo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271528&resulttype=core&format=json

13 May 2020

Mitsue T Brianti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271528&resulttype=core&format=json

13 May 2020

Mahmood Piraee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271528&resulttype=core&format=json

13 May 2020

Alessandra Gambero

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271528&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

21 October 2014

1 reference

5 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271528&resulttype=core&format=json

13 May 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271528&resulttype=core&format=json

13 May 2020

page(s)

16909-16924

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271528&resulttype=core&format=json

13 May 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271528&resulttype=core&format=json

Creative Commons Attribution 4.0 International

13 May 2020

copyright license

start time

21 October 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Adipose tissue, inflammation, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Why a global strategy on diet, physical activity and health?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Phytochemicals and regulation of the adipocyte life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Ilex paraguariensis extract ameliorates obesity induced by high-fat diet: potential role of AMPK in the visceral adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Antiobesity effects of yerba maté extract (Ilex paraguariensis) in high-fat diet-induced obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Anti-inflammatory effects of yerba maté extract (Ilex paraguariensis) ameliorate insulin resistance in mice with high fat diet-induced obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Mate tea (Ilex paraguariensis) promotes satiety and body weight lowering in mice: involvement of glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Anti-obesity and anti-diabetic effects of Yerba Mate (Ilex paraguariensis) in C57BL/6J mice fed a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Yerba mate extract (Ilex paraguariensis) attenuates both central and peripheral inflammatory effects of diet-induced obesity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Phenolic compounds from maté (Ilex paraguariensis) inhibit adipogenesis in 3T3-L1 preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

The in vitro and in vivo effects of yerba mate (Ilex paraguariensis) extract on adipogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

The Effects of Yerba Maté (Ilex Paraguariensis) consumption on IL-1, IL-6, TNF-α and IL-10 production by bone marrow cells in wistar rats fed a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Ilex paraguariensis (yerba mate) improves endocrine and metabolic disorders in obese rats primed by early weaning

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

The effect of mate tea (Ilex paraguariensis) on metabolic and inflammatory parameters in high-fat diet-fed Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Consumption of mate tea (Ilex paraguariensis) decreases the oxidation of unsaturated fatty acids in mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Vascular responses to extractable fractions of Ilex paraguariensis in rats fed standard and high-cholesterol diets

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

High-performance capillary electrophoresis analysis of mate infusions prepared from stems and leaves of Ilex paraguariensis using automated micellar electrokinetic capillary chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Thermogenic effects of commercially available plant preparations aimed at treating human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

The activity of mate saponins (Ilex paraguariensis) in intra-abdominal and epididymal fat, and glucose oxidation in male Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Resveratrol, obesity and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox".

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Cardiovascular protective effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Resveratrol: a review of preclinical studies for human cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Anti-obesity effect of resveratrol-amplified grape skin extracts on 3T3-L1 adipocytes differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Resveratrol inhibits TNF-alpha-induced changes of adipokines in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Resveratrol induces Sirt1-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Resveratrol upregulated SIRT1, FOXO1, and adiponectin and downregulated PPARγ1-3 mRNA expression in human visceral adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: Relative to inhibition of inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Resveratrol inhibits the protein expression of transcription factors related adipocyte differentiation and the activity of matrix metalloproteinase in mouse fibroblast 3T3-L1 preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

An inhibitory effect of resveratrol in the mitotic clonal expansion and insulin signaling pathway in the early phase of adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Resveratrol regulates lipolysis via adipose triglyceride lipase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Up-regulation of adiponectin by resveratrol: the essential roles of the Akt/FOXO1 and AMP-activated protein kinase signaling pathways and DsbA-L.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Resveratrol prevents TNFα-induced suppression of adiponectin expression via PPARγ activation in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Delipidating effect of resveratrol metabolites in 3T3-L1 adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

The Krüppel-like factor KLF2 inhibits peroxisome proliferator-activated receptor-gamma expression and adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Role of Krüppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

The canonical Notch signaling pathway: unfolding the activation mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Genetic analysis of the mammalian transforming growth factor-beta superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Role of C/EBP homologous protein (CHOP-10) in the programmed activation of CCAAT/enhancer-binding protein-beta during adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Requirement of fibroblast growth factor 10 in development of white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Cdk4 promotes adipogenesis through PPARgamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Regulation of Wnt signaling during adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Mechanisms of resveratrol-induced inhibition of clonal expansion and terminal adipogenic differentiation in 3T3-L1 preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Inhibitory effect of (-)-epigallocatechin-3-gallate on lipid accumulation of 3T3-L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: A triple-blind, 6-month follow-up, placebo-controlled, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016909

Effect of serum on the down-regulation of CHOP-10 during differentiation of 3T3-L1 preadipocytes

21 January 2018

1 reference

12 December 2020

Pref-1, a preadipocyte secreted factor that inhibits adipogenesis

1 reference

12 December 2020

Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes

1 reference

12 December 2020

Edible plants, their secondary metabolites and antiobesogenic potential.

1 reference

12 December 2020

Resveratrol inhibits cell differentiation in 3T3-L1 adipocytes via activation of AMPK.

1 reference

12 December 2020

Acute effects of a herb extract formulation and inulin fibre on appetite, energy intake and food choice

1 reference

12 December 2020

Modulatory effects of yerba maté (Ilex paraguariensis) on the PI3K-AKT signaling pathway

1 reference

12 December 2020

Resveratrol increases brown adipose tissue thermogenesis markers by increasing SIRT1 and energy expenditure and decreasing fat accumulation in adipose tissue of mice fed a standard diet

1 reference

12 December 2020

10.3390/MOLECULES191016909

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271528&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271528&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6271528&resulttype=core&format=json